Eric Richman
Director/Board Member chez GAIN THERAPEUTICS, INC.
Fortune : 916 539 $ au 31/03/2024
Profil
Eric I.
Richman is the founder and currently holds multiple positions.
He is the Director of InFUSE Holdings, Inc. which was founded in 2019.
He is also the Chairman of Labconnect LLC, Labconnect Holdings, Inc., and NovelStem International Corp.
He serves as a Director for ADMA Plasma Biologics, Inc., NeuBase Therapeutics, Inc., Gain Therapeutics, Inc., Verimmune, Inc., and LabConnect, Inc. Additionally, Mr. Richman has held former positions as the President, Chief Executive Officer & Director of Tyrogenex, Inc., Chairman of LabConnect, Inc., Director of MedImmune LLC, Director of Theraclone Sciences, Inc., Independent Non-Executive Director of ADMA Biologics, Inc., Director of Therabron Therapeutics, Inc., Director of ZyVersa Therapeutics Operating, Inc., Director of Lev Pharmaceuticals, Inc., Director of PharmAthene, Inc., Director of American Bank (Allentown, Pennsylvania), Director of Neubase Therapeutics, Inc., and Vice President-Corporate Development of MaxCyte, Inc. Mr. Richman has a Master's in Business Administration from the American Graduate School of Management and an undergraduate degree from The Sophie Davis School of Biomedical Education.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GAIN THERAPEUTICS, INC.
1,43% | 10/04/2023 | 232 558 ( 1,43% ) | 876 744 $ | 31/03/2024 |
| 31/12/2023 | 554 054 ( 1,18% ) | 38 784 $ | 31/03/2024 | |
NEUBASE THERAPEUTICS INC
0,06% | 28/03/2024 | 2 247 ( 0,06% ) | 1 011 $ | 31/03/2024 |
Postes actifs de Eric Richman
| Sociétés | Poste | Début |
|---|---|---|
| NOVELSTEM INTERNATIONAL CORP. | Director/Board Member | 01/06/2018 |
| NEUBASE THERAPEUTICS, INC. | Director/Board Member | 12/07/2019 |
| GAIN THERAPEUTICS, INC. | Director/Board Member | - |
Labconnect LLC
 Labconnect LLC Medical/Nursing ServicesHealth Services Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA. | Chairman | 05/09/2018 |
Verimmune, Inc.
 Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Director/Board Member | - |
InFUSE Holdings, Inc.
 InFUSE Holdings, Inc. Medical/Nursing ServicesHealth Services InFUSE Holdings, Inc. owns and operates ambulatory infusion centers. The company was founded by Timothy P. Johnson, Eric I. Richman, David M. Rothenberg, Gregory Gottschlich and is headquartered in Bethesda, MD. | Founder | 01/01/2019 |
Labconnect Holdings, Inc.
 Labconnect Holdings, Inc. Medical/Nursing ServicesHealth Services Labconnect Holdings, Inc. engages in providing laboratory services which include routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical. The company is headquartered in Seattle, WA. | Chairman | 15/09/2018 |
ADMA Plasma Biologics, Inc.
 ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ. | Director/Board Member | - |
LabConnect, Inc.
 LabConnect, Inc. Medical/Nursing ServicesHealth Services LabConnect, Inc. provides central laboratory support services. The company is based in Johnson City, TN and has subsidiaries in Netherlands. The company was founded in 2002. Dawn Gail Sherman has been the CEO of the company since 2022. | Director/Board Member | 01/01/2017 |
Anciens postes connus de Eric Richman
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Eric Richman
| American Graduate School of Management | Masters Business Admin |
| The Sophie Davis School of Biomedical Education | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| NOVELSTEM INTERNATIONAL CORP. | Health Technology |
| MAXCYTE, INC. | Health Technology |
| ADMA BIOLOGICS, INC. | Health Technology |
| NEUBASE THERAPEUTICS, INC. | Health Technology |
| GAIN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Labconnect LLC
Labconnect LLC Medical/Nursing ServicesHealth Services Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA. | Health Services |
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Commercial Services |
Therabron Therapeutics, Inc.
 Therabron Therapeutics, Inc. BiotechnologyHealth Technology Therabron Therapeutics, Inc. provides biotechnology services. It is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company was founded by Aprile Pilon in 2007 and is headquartered in Rockville, MD. | Health Technology |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Health Technology |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
American Bank (Allentown, Pennsylvania)
 American Bank (Allentown, Pennsylvania) Regional BanksFinance Part of American Bank, Inc., American Bank (Allentown, PA) is a financial institution that reflects the goals and aspirations of its customers. The private company offers a range of products and services and provides personalized customer care. Mark W. Jaindl has been the CEO of the company since 1997. | Finance |
ADMA Plasma Biologics, Inc.
ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ. | Health Technology |
Tyrogenex, Inc.
 Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Health Technology |
Labconnect Holdings, Inc.
Labconnect Holdings, Inc. Medical/Nursing ServicesHealth Services Labconnect Holdings, Inc. engages in providing laboratory services which include routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical. The company is headquartered in Seattle, WA. | Health Services |
Neubase Therapeutics, Inc. /Old/
 Neubase Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Neubase Therapeutics, Inc. develops peptide-nucleic acid antisense oligonucleotide platform. Its platform address repeat expansion disorders, with an initial focus on huntington’s disease and myotonic dystrophy, as well as other dominant genetic disorders. The company was founded by Dietrich A. Stephan and is headquartered in Pittsburgh, PA. | Health Technology |
InFUSE Holdings, Inc.
InFUSE Holdings, Inc. Medical/Nursing ServicesHealth Services InFUSE Holdings, Inc. owns and operates ambulatory infusion centers. The company was founded by Timothy P. Johnson, Eric I. Richman, David M. Rothenberg, Gregory Gottschlich and is headquartered in Bethesda, MD. | Health Services |
LabConnect, Inc.
LabConnect, Inc. Medical/Nursing ServicesHealth Services LabConnect, Inc. provides central laboratory support services. The company is based in Johnson City, TN and has subsidiaries in Netherlands. The company was founded in 2002. Dawn Gail Sherman has been the CEO of the company since 2022. | Health Services |
Verimmune, Inc.
Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Health Technology |
